Searchable abstracts of presentations at key conferences in endocrinology

ea0011p848 | Thyroid | ECE2006

Towards the development of a valid quality of life questionnaire for patients with thyroid diseases: Which questions shall we ask?

Watt T , Groenvold M , Rasmussen AK , Bonnema SJ , Hegedüs L , Bjorner JB , Feldt-Rasmussen U

Background and aim: In clinical populations, generic quality of life (QoL) questionnaires should be supplemented with disease-specific questionnaires, which may have higher sensitivity and clinical relevance. For the purpose of developing a comprehensive thyroid QoL questionnaire, we have evaluated the relative importance of various QoL aspects to thyroid patients.Methods: A list of problems (issues) related to thyroid diseases, previously identified thr...

ea0007p306 | Clinical practice | BES2004

Audit of thyroid surgery in a district general hospital

Srinivas|#Shankar U , Jordan T , Plant J , Movva R , Foster G , Rutter M , Ewins D , Worth R

Aim: To assess the outcome of thyroid surgery in a District General Hospital.Methods: Retrospective study of thyroid surgery done over a 3-year period(1999-2002). Indications for surgery, pre and postoperative thyroid status, extent of surgery, post operative complications and post operative histology were evaluated.Results: 124 patients underwent surgery for thyroid disease. 90 % were female and 10 % male, median age of 52 years (...

ea0003p164 | Growth and Development | BES2002

Monitoring insulin-like growth factor-I and IGF binding protein-3 in children and adolescents on GH treatment using filter paper blood spots

Das U , Price D , Khosravi J , Wales J , Butler G , Kibirige M , Diamandi A , Jones J , Hall C , Clayton P

In childhood an appropriate response to GH treatment is achieved by titration of growth response against dose administered, with careful observation for side-effects. In order to evaluate the potential use of IGF monitoring in children treated with GH, a cross-sectional study has been carried in 215 children and adolescents (134 with GH deficiency, 54 with Turner syndrome and 29 with non-GHD growth disorders) treated with GH for 0.2 to 13.7 years.IGF-I ...

ea0002p68 | Neuroendocrinology | SFE2001

SAFETY AND MORTALITY DURING GROWTH HORMONE (GH) REPLACEMENT THERAPY IN 4457 ADULT GH-DEFICIENT PATIENTS - A KIMS DATABASE ANALYSIS

Monson J , Abs R , #B-A|#Bengstonn|# , Feldt-Rasmussen U , Goth M , Koltowska M , Mattsson A , Westberg B , Wilton P

This analysis is based on 4457 patients (2365 males, 2092 females; mean age 44 years, range 18-83) with severe GH deficiency (GHD) enrolled in KIMS (pharmaco-epidemiological survey of GH replacement in adult GH-deficient patients, sponsored by Pharmacia Corporation). The mean duration of adult GH replacement was 2.8 years (range 0.1-11.0) giving 10,779 patient years of follow up. The baseline prevalence of diabetes mellitus prior to GH replacement was 3.7 % (compared with popu...

ea0073aep251 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Bupropion/naltrexone associated psoriasis in an obese patient

Sara Campos Lopes* , Regina Caldas* , Maria José Guimarães , Areal Joana , Alves Marta , Pereira Teresa

*These authors contributed equally to this workIntroductionThe prevalence of obesity has risen dramatically worldwide in the last three decades. Due to this obesity pandemic, a growing demand for weight-loss drugs has emerged. The increased use of these drugs has consequently lead to an increase in the report of adverse reactions.Case reportA 45-year-old woman with past medical history ...

ea0081p199 | Reproductive and Developmental Endocrinology | ECE2022

Is N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) disturbed in polycystic ovary syndrome?

Kałużna Małgorzata , Kompf Pola , Ziemnicka Katarzyna , Tomasz Krauze , Wachowiak-Ochmańska Katarzyna , Wykre¸towicz Andrzej , Guzik Przemyslaw , Ruchala Marek

Introduction: Polycystic ovary syndrome (PCOS) patients present with or without biochemical hyperandrogenism (HAPCOS or non-HAPCOS, respectively). Although cardiometabolic and hormonal abnormalities have been reported in women with PCOS, particularly those with hypertension, direct comparisons between normotensive (blood pressure (BP) <140/90 mmHg) patients with HAPCOS and non-HAPCOS are scarce. Data on N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) in PCO...

ea0065p85 | Bone and calcium | SFEBES2019

The use of 2D-computed tomography scan as a first-line imaging modality in primary hyperparathyroidism

de Jong MC , Hussein Ziad , Jamal K , Morley S , Beale T , Jawad S , Abdel-Aziz TE , Chung TT , Baldeweg SE , Simpson HL , Srirangalingam U , Kurzawinski TR

Background: Minimally invasive parathyroidectomy relies on accurate localisation of the culprit gland. Combination of US plus Technetium 99m-sestamibi is considered the gold standard. CT parathyroid is thought to be a valuable tool in the pre-operative localisation.Aim: To evaluate the diagnostic performance of 2D CT parathyroid in patients with primary hyperparathyroidism (PHP).Methods: This was a single-institution prospective st...

ea0049ep1474 | Thyroid (non-cancer) | ECE2017

Patient with thyroid carcinoma showing thymus-like differentiation: a case study

Kałużna Małgorzata , Janicki Adam , Sygut Jacek , Marszałek Andrzej , Ziemnicka Katarzyna , Ruchała Marek

Thyroid carcinoma showing thymus-like differentiation (CASTLE) is an extremely rare thyroid neoplasm. This type of tumour may arise from branchial pouch remnants or ectopic thymus and is considered as independent clinicopathological entity of thyroid neoplasms. There have been only about 100 cases described in the literature, so far. Here, we have retrospectively analyzed the data from histopathology and clinics of a 70 year old female patient with thyroid CASTLE who underwent...

ea0037ep1148 | Endocrine tumours | ECE2015

Succinate dehydrogenase B associated bladder paragangliomas

Srirangalingam U , Banerjee A , George E , Druce M , Waterhouse M , Chew S L , Peters J , Patki P , Kumar A J , Berney D , Sahdev A , Drake W M , Akker S A

Objective: Succinate dehydrogenase B (SDHB) germline mutations are associated with predominantly extra-adrenal paraganglioma (PGLs) and high rates of metastatic disease. Bladder paragangliomas are a rare form of chromaffin cell tumours arising from the bladder wall. The aim of the study is to highlight the preponderance of bladder paragangliomas associated with SDHB gene mutations.Design: Retrospective case series.Patients: Five of...

ea0037ep1149 | Endocrine tumours | ECE2015

Excision of phaeochromocytoma and paraganglioma involving the great vessels

Srirangalingam U , Gunganah K , Parvanta L , Metcalfe K , Besser G M , Sahdev A , Flora H S , Bhattacharya S , Carpenter R , Akker S , Edmondson S J , Drake W

Objective: The aim of the study was to describe the surgical management of phaeochromocytomas and paragangliomas which lie in close proximity to or involve the great vessels including the aorta and vena cava.Design: Retrospective case-series. Patients: five subjects undergoing surgical excision of either a phaeochromocytoma or paraganglioma involving the great vessels seen at St Bartholomew’s Hospital, UK (2004–2013).Meas...